ANG Lifesciences India Ltd - 540694 - Considered And Approved The Standalone And Consolidated Audited Financial Results For The Quarter And Year Ended 31St March, 2023 Along With The Auditor'S Report Thereon.
Considered and approved the Standalone and Consolidated Audited Financial Results for the quarter and year ended 31st March, 2023 along with the Auditor's Report thereon. ANG Lifesciences India Ltd - 540694 - Announcement under Regulation 30 (LODR)-Meeting Updates
Pursuant to Regulation 30 and 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that the Board of Directors of ANG Lifesciences India Limited at their Meeting held today i.e. Tuesday, May 30, 2023, at the Registered Office of the Company situated at Darbara Complex, SCO- 113, District Shopping Centre, B Block, Ranjit Avenue, Amritsar-143001 transacted the business as per notice dated 23.05.2023. ANG Lifesciences India Ltd - 540694 - Announcement under Regulation 30 (LODR)-Meeting Updates
Pursuant to Regulation 30 and 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that the Board of Directors of ANG Lifesciences India Limited at their Meeting held today i.e. Tuesday, May 30, 2023, at the Registered Office of the Company situated at Darbara Complex, SCO- 113, District Shopping Centre, B Block, Ranjit Avenue, Amritsar-143001 transacted the business as per notice dated 23.05.2023. ANG Lifesciences India Ltd - 540694 - Compliance Certificate Pursuant To Reg. 7(3) Of SEBI, LODR, 2015 For The Year Ended As At 31.03.2023
Compliance certificate pursuant to Reg. 7(3) of SEBI, LODR, 2015 for the year ended as at 31.03.2023 ANG Lifesciences India Ltd - 540694 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Certificate under Reg. 74(5) of SEBI (Depositories & Participants) 2018 for the quarter ended 31.03.2023 ANG Lifesciences India Ltd - 540694 - Board Meeting Intimation for Intimation Of Board Meeting
ANG Lifesciences India Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2023 ,inter alia, to consider and approve Pursuant to reg 29 of the SEBI LODR, the meeting of the Board of Directors is scheduled to be held on tuesday 30th May, 2023 to consider the matter as enclosed herewith the notice of Board Meeting ANG Lifesciences India Ltd - 540694 - Submission Of Voting Result Along With Scrutinizer'S Report Pursuant To Regulation 44(3) Of The SEBI (Listing Obligation And Disclosure Requirements) Regulation, 2015.
Pursuant to Regulation 44 of the Listing Regulations, please find enclosed herewith the details of voting results inclusive of remote e-voting during the EGM of the company held on Wednesday, May 03rd, 2023 through Video Conferencing ('VC')/ other Audio-Visual Means ('OAVM'). ANG Lifesciences India Ltd - 540694 - Proceedings Of The Extra Ordinary General Meeting Dated 03.05.2023
Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed herewith the summary of proceedings of the Extra Ordinary General Meeting (EGM) held on Wednesday, May, 03, 2023 at 12:00 p.m. through Video Conferencing ("VC")/Other Audio Visual Means ("OAVM") in accordance with the circular(s) issued by the Ministry of Corporate Affairs and the Securities and Exchange Board of India for transacting the business(es) mentioned in the Notice dated 05th April, 2023 convening the EGM. You are requested to take the same on record. ANG Lifesciences India Ltd - 540694 - Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A
Format of Initial Disclosure to be made by an entity identified as a Large Corporate. Sr. No. Particulars Details 1Name of CompanyANG Lifesciences India Ltd 2CIN NO.L24230PB2006PLC030341 3 Outstanding borrowing of company as on 31st March / 31st December, as applicable (in Rs cr) 0.00 4Highest Credit Rating during the previous FY BBB- 4aName of the Credit Rating Agency issuing the Credit Rating mentioned in (4)INFOMERICS VALUATION AND RATING PVT. LTD. 5Name of Stock Exchange# in which the fine shall be paid, in case of shortfall in the required borrowing under the frameworkBSE We confirm that we are a Large Corporate as per the applicability criteria given under the SEBI circular SEBI/HO/DDHS/CIR/P/2018/144 dated November 26, 2018. No Name of the Company Secretary: Renu Kaur Designation: Company Secretary EmailId: [email protected] Name of the Chief Financial Officer: NIL Designation: nil EmailId: [email protected] Date: 21/04/2023 Note: In terms para of 3.2(ii) of the circular, beginning F.Y 2022, in the event of shortfall in the mandatory borrowing through debt securities, a fine of 0.2% of the shortfall shall be levied by Stock Exchanges at the end of the two-year block period. Therefore, an entity identified as LC shall provide, in its initial disclosure for a financial year, the name of Stock Exchange to which it would pay the fine in case of shortfall in the mandatory borrowing through debt markets. ANG Lifesciences India Ltd - 540694 - Notice Of Extra Ordinary General Meeting Of The Company.
Pursuant to Regulation 30 read with Part A of Schedule III, we are enclosing herewith a copy of notice of the Extra Ordinary General Meeting (EGM) of ANG Lifesciences India Ltd ("the Company') to be held on Wednesday, 03rd May, 2023 at 12:00 p.m. (IST) through Video Conferencing ("VC")/Other Audio-Visual Means ("OAVM").